Morphic Holding, Inc. (MORF) Financials
MORF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 722.5 million | 25.5 million |
| 2023-09-30 | 743.6 million | 20.4 million |
| 2023-06-30 | 748.7 million | 19.4 million |
| 2023-03-31 | 441.9 million | 15.4 million |
MORF Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -28.7 million | 10.5 million |
| 2023-09-30 | -29.6 million | 10.5 million |
| 2023-06-30 | -23.3 million | 10.3 million |
| 2023-03-31 | -32.0 million | 9.6 million |
MORF Net Income
No data available :(
MORF Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 704.3 million | - | 2.3 million |
| 2023-09-30 | 725.1 million | - | 2.7 million |
| 2023-06-30 | 731.4 million | - | 3.1 million |
| 2023-03-31 | 421.3 million | - | 3.5 million |
MORF Shares Outstanding
MORF Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 93000 | 39.9 million | 9.6 million | - |
| 2023-09-30 | 305000 | 34.4 million | 10.4 million | - |
| 2023-06-30 | 293000 | 35.7 million | 9.6 million | - |
| 2023-03-31 | 550000 | 30.4 million | 9.3 million | - |
MORF Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | -60.2 million | 280000 |
| 2023-09-30 | - | 286000 |
| 2023-06-30 | 60.2 million | 268000 |
| 2023-03-31 | 521000 | 257000 |
MORF
Price: $28.07
52 week price:
Earnings Per Share: -3.59 USD
P/E Ratio: -10.56
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 148800
Market Capitalization: 1.5 billion